Potential therapeutic implications of cancer stem cells in glioblastoma - Wikidata - wikimedia - TriplyDB

Potential therapeutic implications of cancer stem cells in glioblastoma

Potential therapeutic implications of cancer stem cells in glioblastoma

http://www.wikidata.org/entity/Q33965491

about

Impairment of glioma stem cell survival and growth by a novel inhibitor for Survivin-Ran protein complex Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma Long Non-Coding RNAs: The Key Players in Glioma Pathogenesis The three-layer concentric model of glioblastoma: cancer stem cells, microenvironmental regulation, and therapeutic implications Brain tumor stem cells: Molecular characteristics and their impact on therapy Serum-Induced Differentiation of Glioblastoma Neurospheres Leads to Enhanced Migration/Invasion Capacity That Is Associated with Increased MMP9 Angiogenic inhibition in high-grade gliomas: past, present and future.Small G protein Rac GTPases regulate the maintenance of glioblastoma stem-like cells in vitro and in vivo.Multiple spatially related pharmacophores define small molecule inhibitors of OLIG2 in glioblastoma The NFκB inhibitor, SN50, induces differentiation of glioma stem cells and suppresses their oncogenic phenotype Progesterone induces the growth and infiltration of human astrocytoma cells implanted in the cerebral cortex of the rat.Targeting glioma stem cells in vivo by a G-quadruplex-stabilizing synthetic macrocyclic hexaoxazole.Targeting PTPRZ inhibits stem cell-like properties and tumorigenicity in glioblastoma cells.Therapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms.CXCL12 mediates trophic interactions between endothelial and tumor cells in glioblastoma Biology, genetics and imaging of glial cell tumours Genome-wide profiling identified a set of miRNAs that are differentially expressed in glioblastoma stem cells and normal neural stem cells.Current status of gene therapy for brain tumors.Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance.Molecular alterations in glioblastoma: potential targets for immunotherapy.A novel oncolytic herpes simplex virus that synergizes with phosphoinositide 3-kinase/Akt pathway inhibitors to target glioblastoma stem cells.Treatment of Invasive Brain Tumors Using a Chain-like Nanoparticle.Drosophila melanogaster as a model system for human brain cancers.Unlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacy Effect of γ34.5 deletions on oncolytic herpes simplex virus activity in brain tumors.RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.Targeting JNK for therapeutic depletion of stem-like glioblastoma cells Hypofractionated Radiotherapy and Stereotactic Boost with Concurrent and Adjuvant Temozolamide for Glioblastoma in Good Performance Status Elderly Patients - Early Results of a Phase II Trial.Biological and clinical implications of cancer stem cells in primary brain tumors.Combinatorial strategies for oncolytic herpes simplex virus therapy of brain tumors.Anti-Cancer Effect of Ginsenoside F2 against Glioblastoma Multiforme in Xenograft Model in SD Rats Glioma-initiating cell elimination by metformin activation of FOXO3 via AMPK.MELK-dependent FOXM1 phosphorylation is essential for proliferation of glioma stem cells.Telomestatin impairs glioma stem cell survival and growth through the disruption of telomeric G-quadruplex and inhibition of the proto-oncogene, c-Myb.CBX Chromodomain Inhibition Enhances Chemotherapy Response in Glioblastoma Multiforme.G-quadruplex ligand-induced DNA damage response coupled with telomere dysfunction and replication stress in glioma stem cells.Mathematical modeling of PDGF-driven glioblastoma reveals optimized radiation dosing schedules Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells.A three-dimensional collagen scaffold cell culture system for screening anti-glioma therapeutics.

P2860

Q24306474-AC191535-3A61-4F14-8A06-310A0517D1B1 Q26765758-152234C7-9E29-4B17-B224-D272D1435E68 Q26776219-2B92B807-BCB3-4B61-8196-5441A321B6AF Q26800873-7675DEFC-AEC8-4BC5-8E3D-4949E5232CF3 Q26829663-A0E0CFD5-0F81-45C4-9A7A-35F111535DA8 Q27003138-4BCC2F65-975A-461A-977A-AB3897BA9C83 Q28551757-32FEAC03-4E81-467C-9B42-B4DC3D416388 Q30455596-AACFC048-AC6F-4319-8C65-ACF1CEF44ACD Q33566796-A5941923-8DC4-4C6A-B0DC-624C55128380 Q33618337-C0DFA7AE-565E-4DD4-B6D0-A8B945BCCA17 Q33631488-B7B542E7-2E45-498D-B29D-7B4C0807EDF1 Q33745937-39236F0B-64A9-4428-AEAA-2EE662B3CEF7 Q33804001-128D3A0F-7906-4D63-B50C-BD33940F1025 Q33912275-27930B93-4B14-4809-93DB-8B4FDCDBDB07 Q34154786-4215E97E-F355-4EA8-AC7B-4B34C88F3BD5 Q34200294-C7D8E2C9-FDA3-4EBD-BB94-7938CA0795C8 Q34203979-B26FDE43-75F7-4F1F-80B8-B2DEBF321CD6 Q34257360-1EC80ED5-D950-4DCF-BD97-153AEEA03DCD Q34318157-4A08FA04-DF04-4E7A-AFA3-D908653359D5 Q34662363-338F2DDA-C896-4296-B6F6-C63E1A90121B Q34870511-0D70865B-53AD-4E4F-B7C7-C0F8D2BEDA75 Q35023915-95356DD5-593A-4F38-ADB9-F543E87F15E8 Q35251878-F9965972-DE2A-45E8-B33E-C2C73725CE03 Q35566228-F97E8837-146D-4B22-B77F-F0351A609820 Q35657822-562A20B6-AFF5-45EA-84E8-7E85E482BA9D Q35867997-21213625-E3E6-418C-B219-114C6EFA3E00 Q36020835-248C6C4E-6ED0-42F0-846D-B9E41EE64031 Q36103845-20537625-BB39-42B5-8B3F-7F80F3E61338 Q36320980-09708529-9000-465F-BD9C-A3B3059D6724 Q36562573-B94974F9-9D60-49EF-920E-4B3BAF0F0876 Q36849213-B2A25F55-2C73-4A44-AA12-3127AAB1D5EB Q36861061-4C7BB039-3FDD-4755-9788-D90A8E788292 Q36861418-ECEB55C1-6971-4C63-A321-28EF066B5EDF Q37098261-ED444F10-30F8-42FF-B69C-54ADCF54DD49 Q37494834-186C8939-7181-4187-BE11-F9788FD7B5BA Q37517517-D652223C-5E55-4EEE-85E4-6B53C37732A2 Q37524887-1D348447-26CA-48B3-A8E1-A3979CE079D0 Q37581947-B0F500D3-9DEB-41B1-8795-0131C68B746F Q37603641-0C34FA31-0408-4B31-8223-4FABDB293ABB Q37636717-5E02E504-2A9C-4109-96AA-5535C0DE26FC

P2860

Potential therapeutic implications of cancer stem cells in glioblastoma

http://www.wikidata.org/entity/Q33965491

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Potential therapeutic implications of cancer stem cells in glioblastoma

@ast

Potential therapeutic implications of cancer stem cells in glioblastoma

@en

type

label

Potential therapeutic implications of cancer stem cells in glioblastoma

@ast

Potential therapeutic implications of cancer stem cells in glioblastoma

@en

prefLabel

Potential therapeutic implications of cancer stem cells in glioblastoma

@ast

Potential therapeutic implications of cancer stem cells in glioblastoma

@en

P1433

Q33965491-B395B8B9-3731-4167-B48F-28D1D499B270

P1476

Q33965491-F400667D-2D45-4B0A-A8B2-87D7CD1EDBCF

P2093

Q33965491-9A103CFE-6B79-4363-B14E-E39CE580DE5F

Q33965491-CA59978E-E0A8-45FE-85F2-0C72EEE82CCB

Q33965491-DD708DC5-A80E-41AD-8A75-3A67E4B3A74C

P2860

Q33965491-013FC5E9-B71C-41B8-90A7-9EF173A1A284

Q33965491-0228A972-1E40-4B3A-B941-A81ABC301600

Q33965491-02DD0474-9404-4B34-A773-996168B513F1

Q33965491-02E219C5-2EB6-42C1-948D-3A797A807887

Q33965491-030907FD-A45E-448A-A964-969A4407319F

Q33965491-036BB792-ED1E-401F-A683-24CAF2B98A52

Q33965491-0A7266FF-997B-4B0D-B1F7-22AA34DDAC50

Q33965491-0A94B606-000E-42DE-8C29-765916161802

Q33965491-0F79E685-26B4-4F68-8AD9-89D045DC6157

Q33965491-0FAAFA89-C89D-47D9-BA9C-D790D20CF46D

P304

Q33965491-7A75BD52-199E-466F-B525-372B54A889CD

P31

Q33965491-AEDE3993-F43C-43BD-959E-0F921A903346

P356

Q33965491-882A2CA1-6F30-42AE-9E8D-4D48D31857DD

P407

Q33965491-BE903D1B-9517-4959-8D8A-08D60BAAA0A0

P433

Q33965491-8E2040C1-4628-4C7C-BCAF-337498EA9042

P478

Q33965491-08108642-D743-457C-8972-ABD6169ED5BE

P577

Q33965491-6EF0F9D2-7A8F-4AD0-87FC-DE89B258AE28

P5875

Q33965491-BD6EAA84-85EC-423A-B343-FA8AC913BE44

P698

Q33965491-DEC38A23-32F0-4DA5-A1F2-4676EF55452E

P932

Q33965491-7A58E74F-ED59-4E3B-82D9-E912F8C09004

P356

J.BCP.2010.04.035

P1433

Biochemical Pharmacology

P1476

Potential therapeutic implications of cancer stem cells in glioblastoma

@en

P2093

Jeremy N Rich

http://www.w3.org/2001/XMLSchema#string

Lin Cheng

http://www.w3.org/2001/XMLSchema#string

Shideng Bao

http://www.w3.org/2001/XMLSchema#string

P2860

miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

The Hallmarks of Cancer

Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells

Sox11 prevents tumorigenesis of glioma-initiating cells by inducing neuronal differentiation

Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling

A distinct "side population" of cells with high drug efflux capacity in human tumor cells

Cancerous stem cells can arise from pediatric brain tumors

Identification of cells initiating human melanomas

Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation

Phenotypic characterization of human colorectal cancer stem cells

P304

654-665

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BCP.2010.04.035

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44587023

http://www.w3.org/2001/XMLSchema#string

P698

20457135

http://www.w3.org/2001/XMLSchema#string

P932

2897968

http://www.w3.org/2001/XMLSchema#string